Annals of Diagnostic Pathology
Volume 15, Issue 2 , Pages 140-144 , April 2011

Papillary carcinoma with diffuse papillomatosis of gallbladder and cystic duct

  • Kemal Kosemehmetoglu, MD

      Affiliations

    • Department of Pathology, Hacettepe University, 06100 Ankara, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 312 305 1563; fax: +90 312 305 2621.
    • ,
  • Erhan Akpinar, MD

      Affiliations

    • Department of Radiology, Hacettepe University, 06100 Ankara, Turkey
    • ,
  • Cenk Sokmensuer, MD

      Affiliations

    • Department of Pathology, Hacettepe University, 06100 Ankara, Turkey
    • ,
  • Erhan Hamaloglu, MD

      Affiliations

    • Department of Surgery, Hacettepe University, 06100 Ankara, Turkey

References 

  1. Lee SS, Kim MH, Lee SK, et al. Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer. 2004;100(4):783–793
  2. Yeung YP, AhChong K, Chung CK, et al. Biliary papillomatosis: report of seven cases and review of English literature. J Hepatobiliary Pancreat Surg. 2003;10(5):390–395
  3. Tetikkurt S, Şahan E, İğdem-Akyıldız A. Gallbladder adenocarcinoma arising from papillomatosis. Turkish J Pathol. 2000;16:113–115
  4. Albores-Saavedra J, Murakata L, Krueger JE, et al. Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts. Cancer. 2000;89(3):508–515
  5. Lam CM, Yuen ST, Yuen WK, et al. Biliary papillomatosis. Br J Surg. 1996;83(12):1715–1716
  6. Taguchi J, Yasunaga M, Kojiro M, et al. Intrahepatic and extrahepatic biliary papillomatosis. Arch Pathol Lab Med. 1993;117(9):944–947
  7. Ahaouche M, Cazals-Hatem D, Watrin T, et al. Malignant biliary papillomatosis: analysis of p53 expression. Ann Pathol. 2004;24(4):364–367
  8. Sotiropoulos GC, Lang H, Nadalin S, et al. Papillomatosis confined to the distal biliary tract–a rare cause of obstructive jaundice: report of a case. Surg Today. 2003;33(10):781–784
  9. Holtkamp W, Reis HE. Papillomatosis of the bile ducts: papilloma-carcinoma sequence. Am J Gastroenterol. 1994;89(12):2253–2255
  10. Goldin RD, Roa JC. Gallbladder cancer: a morphological and molecular update. Histopathology. 2009;55(2):218–229
  11. el-Deiry WS, Harper JW, O'Connor PM, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 1994;54(5):1169–1174
  12. Reed SI, Bailly E, Dulic V, et al. G1 control in mammalian cells. J Cell Sci Suppl. 1994;18:69–73
  13. Chen CY, Oliner JD, Zhan Q, et al. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci U S A. 1994;91(7):2684–2688
  14. Wistuba II, Gazdar AF, Roa I, et al. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol. 1996;27(4):360–365
  15. Teh M, Wee A, Raju GC. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer. 1994;74(5):1542–1545
  16. Puhalla H, Wrba F, Kandioler D, et al. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer. Anticancer Res. 2007;27(3B):1679–1684

PII: S1092-9134(10)00024-9

doi: 10.1016/j.anndiagpath.2010.02.004

Annals of Diagnostic Pathology
Volume 15, Issue 2 , Pages 140-144 , April 2011

Article Tools

* Image Usage & Resolution